SIO GENE THERAPIES INC (SIOX) Stock Overview
USA - NASDAQ:SIOX - US8293991043 - Common Stock
SIOX Key Statistics, Chart & Performance
The current stock price of SIOX is 0.415 USD. In the past month the price increased by 1.47%. In the past year, price decreased by -40.98%.
SIOX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.62 | 385.71B | ||
| AMGN | AMGEN INC | 12.67 | 148.80B | ||
| GILD | GILEAD SCIENCES INC | 14.8 | 142.13B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.29 | 101.15B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 61.07B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.27 | 59.35B | ||
| ARGX | ARGENX SE - ADR | 81.59 | 46.29B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.67 | 38.56B | ||
| INSM | INSMED INC | N/A | 30.85B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.26B | ||
| NTRA | NATERA INC | N/A | 23.13B | ||
| BIIB | BIOGEN INC | 9.05 | 21.24B |
Related stock screener links
About SIOX
Company Profile
Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company is headquartered in New York City, New York and currently employs 12 full-time employees. The company went IPO on 2015-06-11. The firm is focused on pushing the boundaries of gene therapy to develop treatments for debilitating rare neurodegenerative diseases, including GM1 gangliosidosis and Tay-Sachs/Sandhoff disease. The firm is primarily focused on pre-clinical research and development initiatives in gene therapy.
Company Info
SIO GENE THERAPIES INC
1501 Broadway, 12Th Floor
New York City NEW YORK 10036 US
CEO: Pavan Cheruvu
Employees: 12
Phone: 18777464891.0
SIO GENE THERAPIES INC / SIOX FAQ
What is the stock price of SIO GENE THERAPIES INC today?
The current stock price of SIOX is 0.415 USD. The price increased by 2.09% in the last trading session.
What is the ticker symbol for SIO GENE THERAPIES INC stock?
The exchange symbol of SIO GENE THERAPIES INC is SIOX and it is listed on the Nasdaq exchange.
On which exchange is SIOX stock listed?
SIOX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SIO GENE THERAPIES INC stock?
7 analysts have analysed SIOX and the average price target is 5.1 USD. This implies a price increase of 1128.92% is expected in the next year compared to the current price of 0.415. Check the SIO GENE THERAPIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SIO GENE THERAPIES INC worth?
SIO GENE THERAPIES INC (SIOX) has a market capitalization of 30.70M USD. This makes SIOX a Nano Cap stock.
How many employees does SIO GENE THERAPIES INC have?
SIO GENE THERAPIES INC (SIOX) currently has 12 employees.
What are the support and resistance levels for SIO GENE THERAPIES INC (SIOX) stock?
SIO GENE THERAPIES INC (SIOX) has a support level at 0.41 and a resistance level at 0.42. Check the full technical report for a detailed analysis of SIOX support and resistance levels.
Should I buy SIO GENE THERAPIES INC (SIOX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SIOX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SIOX, evaluating the profitability, health, valuation and growth aspects
- SIO GENE THERAPIES INC (SIOX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SIO GENE THERAPIES INC (SIOX) Sales and EPS estimates to see what analysts future expectations are.
- SIO GENE THERAPIES INC (SIOX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SIO GENE THERAPIES INC (SIOX) Insider and Institutional Ownership to learn about the owners and their transactions.
- SIO GENE THERAPIES INC (SIOX) Stock Chart to make your own analysis
- SIO GENE THERAPIES INC (SIOX) Latest news and press-releases to stay up to date.
Does SIO GENE THERAPIES INC (SIOX) stock pay dividends?
SIOX does not pay a dividend.
When does SIO GENE THERAPIES INC (SIOX) report earnings?
SIO GENE THERAPIES INC (SIOX) will report earnings on 2023-06-12, before the market open.
What is the Price/Earnings (PE) ratio of SIO GENE THERAPIES INC (SIOX)?
SIO GENE THERAPIES INC (SIOX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.68).
SIOX Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to SIOX. When comparing the yearly performance of all stocks, SIOX is a bad performer in the overall market: 81.9% of all stocks are doing better.
SIOX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SIOX. SIOX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
SIOX Financial Highlights
Over the last trailing twelve months SIOX reported a non-GAAP Earnings per Share(EPS) of -0.68. The EPS increased by 2.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
SIOX Forecast & Estimates
7 analysts have analysed SIOX and the average price target is 5.1 USD. This implies a price increase of 1128.92% is expected in the next year compared to the current price of 0.415.